{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:29:50Z","timestamp":1759616990304},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.pnpbp.2008.05.016","type":"journal-article","created":{"date-parts":[[2008,5,30]],"date-time":"2008-05-30T09:53:35Z","timestamp":1212141215000},"page":"1545-1548","source":"Crossref","is-referenced-by-count":23,"title":["No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients"],"prefix":"10.1016","volume":"32","author":[{"given":"Seung-Gul","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Eun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyonggin","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se-Won","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heon-Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changsu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Ku","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Nam","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sook-Haeng","family":"Joe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Kwa","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leen","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2008.05.016_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0166-2236(98)01273-9","article-title":"Neurotrophin trafficking by anterograde transport","volume":"21","author":"Altar","year":"1998","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib2","doi-asserted-by":"crossref","first-page":"11347","DOI":"10.1073\/pnas.89.23.11347","article-title":"Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo","volume":"89","author":"Altar","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jnr.10440","article-title":"Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs","volume":"71","author":"Bai","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.mp.4002142","article-title":"Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions","volume":"13","author":"Bakker","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neulet.2005.12.033","article-title":"Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese population","volume":"397","author":"Chen","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-8993(02)03215-8","article-title":"Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration","volume":"954","author":"Chlan-Fourney","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.08.012","article-title":"Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder","volume":"1118","author":"Choi","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1034\/j.1600-0447.2002.01331.x","article-title":"Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations","volume":"106","author":"Freudenreich","year":"2002","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1745-7254.2006.00279.x","article-title":"Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients","volume":"27","author":"Fu","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib11","series-title":"Abnormal Involuntary Movement Scale (AIMS). ECDEU assessment manual for psychopharmacology","first-page":"534","author":"Guy","year":"1976"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib12","series-title":"Structured clinical interview for DSM-IV axis I disorder\u2014Korean version","author":"Han","year":"2000"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ajmg.b.20078","article-title":"Association between brain-derived neurotrophic factor 196 G\/A polymorphism and personality traits in healthy subjects","volume":"124","author":"Itoh","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/schbul\/19.2.303","article-title":"Tardive dyskinesia","volume":"19","author":"Jeste","year":"1993","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.pnpbp.2006.02.008","article-title":"Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study","volume":"30","author":"Jonsson","year":"2006","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib16","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1097\/00004714-198808001-00010","article-title":"Tardive dyskinesia: prevalence, incidence, and risk factors","volume":"8","author":"Kane","year":"1988","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1073\/pnas.88.3.961","article-title":"Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3","volume":"88","author":"Knusel","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib20","first-page":"66","article-title":"Pharmacogenetic studies investigating the adverse effects of antipsychotics","volume":"4","author":"Lee","year":"2007","journal-title":"Psychiatry Invest"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/smi.1085","article-title":"No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and post-traumatic stress disorder","volume":"22","author":"Lee","year":"2006","journal-title":"Stress Health"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000103576","article-title":"No association between dopamine D4 receptor gene \u2212521 C\/T polymorphism and tardive dyskinesia in schizophrenia","volume":"55","author":"Lee","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/hup.875","article-title":"No evidence for an association between G protein \u03b23 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia","volume":"22","author":"Lee","year":"2007","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/NMM:5:3:243","article-title":"Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients","volume":"5","author":"Liou","year":"2004","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib25","first-page":"159","article-title":"Free radical involvement in neuropsychiatric illnesses","volume":"31","author":"Lohr","year":"1995","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","article-title":"Oxidative mechanisms and tardive dyskinesia","volume":"17","author":"Lohr","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib27","series-title":"World congress on psychiatric genetics","article-title":"A genetic study of tardive dyskinesia in an Italian population of chronic schizophrenics","author":"Macciardi","year":"1996"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0888-7543(91)90436-I","article-title":"Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations","volume":"10","author":"Maisonpierre","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1601-183X.2007.00301.x","article-title":"Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia","volume":"6","author":"Mercader","year":"2007","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.10079","article-title":"Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms","volume":"51","author":"Momose","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1034\/j.1600-0447.2001.00401.x","article-title":"Familial occurrence of tardive dyskinesia","volume":"104","author":"M\u00fcller","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.mp.4001575","article-title":"BDNF gene is a risk factor for schizophrenia in a Scottish population","volume":"10","author":"Neves-Pereira","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib33","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1097\/00001756-199808240-00030","article-title":"Medial nigral dopamine neurons have rich neurotrophin support in humans","volume":"9","author":"Nishio","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.parkreldis.2003.12.003","article-title":"Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease","volume":"10","author":"Parsian","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ajmg.b.30266","article-title":"The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study","volume":"141","author":"Rosa","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0091-3057(94)90085-X","article-title":"Possible genetic factors underlying the pathophysiology of tardive dyskinesia","volume":"49","author":"Rosengarten","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/j.1440-1614.2000.00737.x","article-title":"The current status of tardive dyskinesia","volume":"34","author":"Sachdev","year":"2000","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","article-title":"Research diagnosis for tardive dyskinesia","volume":"39","author":"Schooler","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s002130000521","article-title":"Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility","volume":"152","author":"Segman","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.mp.4000842","article-title":"Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia","volume":"6","author":"Segman","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib42","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2165\/00003495-199652060-00006","article-title":"Pharmacological options for the management of dyskinesias","volume":"52","author":"Shale","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.mp.4000249","article-title":"Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients","volume":"2","author":"Steen","year":"1997","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib44","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/BF02247127","article-title":"Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains","volume":"102","author":"Tamminga","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.schres.2004.08.004","article-title":"Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements","volume":"74","author":"Tan","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib46","first-page":"431","article-title":"The pathophysiologic basis of tardive dyskinesia","volume":"12","author":"Tarsy","year":"1977","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib47","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/mds.20823","article-title":"Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?","volume":"21","author":"Tarsy","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2006.03.011","article-title":"No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population","volume":"84","author":"Watanabe","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib49","first-page":"165","article-title":"Familial occurrence of tardive dyskinesia","volume":"42","author":"Weinhold","year":"1981","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.schres.2006.12.008","article-title":"Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis","volume":"91","author":"Xu","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib51","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1176\/ajp.138.12.1618","article-title":"Familial tardive dyskinesia","volume":"138","author":"Yassa","year":"1981","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.016_bib52","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/schbul\/18.4.701","article-title":"Gender differences in tardive dyskinesia: a critical review of the literature","volume":"18","author":"Yassa,","year":"1992","journal-title":"Schizophr Bull"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608001516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608001516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T05:25:23Z","timestamp":1545974723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584608001516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0278584608001516"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2008.05.016","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}